Delivery Order SPE2DB22D2206-SPE2DB24FKC79

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 18, 2024. The contract has a ceiling value of $7,685.70 and is a firm fixed-price delivery order with an ultimate completion date of April 19, 2024. There is no set-aside designation for this...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,757.74. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $4,006.54 and a completion date of January 29, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp also holds...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,769.45 and is a firm fixed-price delivery order. It has an ultimate completion date of March 5, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award is for the supply of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,927.77 and is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. The contract was awarded on April 3, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 26, 2025, with a ceiling value of $2,284.86. The contract is a delivery order with a firm fixed price, and the ultimate completion date is set for February 27, 2025. The place of performance is...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, on May 23, 2024. The contract has a ceiling value of $11,887.64 and is a firm fixed-price delivery order. It does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,478.06 and a completion date of March 28, 2025. It is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $3,819.92 and is a Delivery Order with a Firm Fixed Price pricing type. It was awarded on May 1, 2024, with a completion date of May 2, 2024. The contract does not have a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKC79
    Delivery Order

This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 4, 2024 with a ceiling value of $3,832.75. The contract is a Firm Fixed Price Delivery Order that runs through September 5, 2024. It is not a set-aside contract. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is likely part of a larger Indefinite Delivery Contract (IDC) the company has in place with the DLA Troop Support Medical program to provide a wide range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide.

Generated 12/4/24, 9:31 AM